Molecular Basis of Fibrinogen Deficiency

Publisher： Karger

E-ISSN： 1424-8840|35|1-2|187-198

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.35, Iss.1-2, 2006-06, pp. : 187-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Incidence and molecular basis of CD36 deficiency in Shanghai population

By  

TRANSFUSION, Vol. 55, Iss. 3, 2015-03 ,pp. : 666-673

John Wiley & Sons Inc

Access to resources Recommend Favorite

Postauthorization safety study of Clottafact®, a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study

By  

VOX SANGUINIS, Vol. 113, Iss. 2, 2018-02 ,pp. : 120-127

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial

By  

TRANSFUSION, Vol. 58, Iss. 2, 2018-02 ,pp. : 413-422

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 16, Iss. 2, 2018-02 ,pp. : 253-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

On the Identification of Beneficial and Detrimental Molecular Forms of Fibrinogen

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 2-3, 2000-01 ,pp. : 179-186

Karger

Access to resources Recommend Favorite